PG
45
-5
GPC
53
-3
GE
72
4
CINF
66
2
ALLE
41
-5
LRCX
71
22
APA
48
-4
ADT
48
-2
WDC
66
2
DVN
42
-2
GLW
67
3
VMC
53
3
DUK
57
2
PCG
72
2
AON
67
2
TSCO
50
-3
ADM
45
-2
DTE
40
4
VLO
48
10
UNP
36
-3
PG
45
-5
GPC
53
-3
GE
72
4
CINF
66
2
ALLE
41
-5
LRCX
71
22
APA
48
-4
ADT
48
-2
WDC
66
2
DVN
42
-2
GLW
67
3
VMC
53
3
DUK
57
2
PCG
72
2
AON
67
2
TSCO
50
-3
ADM
45
-2
DTE
40
4
VLO
48
10
UNP
36
-3
Financhill
Back

Freeport-McMoRan, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
72

FCX
Freeport-McMoRan, Inc.

Last Price:
$47.94
Seasonality Move:
7.92%
Sell
31

MNPR
Monopar Therapeutics, Inc.

Last Price:
$65.70
Seasonality Move:
25.93%
Buy
72
Freeport-McMoRan, Inc. (FCX) is a Buy

Is Freeport-McMoRan, Inc. a Buy, Sell or Hold?

  • The current Freeport-McMoRan, Inc. [FCX] share price is $47.92. The Score for FCX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • FCX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $65.99. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCX Stock Price Chart

What is Freeport-McMoRan, Inc.'s stock price today?

  • The Freeport-McMoRan, Inc. share price today is $47.92
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $65.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

FCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.77 Buy
Relative Strength Index (14 RSI): 71.08 Buy
Chaikin Money Flow: 3468354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.6 - 46.62) Buy
Bollinger Bands (100): (39.69 - 45.07) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.42 Sell
Relative Strength Index (14 RSI): 32.25 Sell
Chaikin Money Flow: -36886 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.08 - 86.32) Sell
Bollinger Bands (100): (45.17 - 89.09) Sell

FCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.19 Buy
20-day SMA: 44.47 Buy
50-day SMA: 42.44 Buy
200-day SMA: 40.98 Buy
8-day EMA: 47.04 Buy
20-day EMA: 45.17 Buy
50-day EMA: 43.35 Buy
200-day EMA: 42 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 73.2 Sell
20-day SMA: 79.37 Sell
50-day SMA: 82.12 Sell
200-day SMA: 52.13 Buy
8-day EMA: 72.25 Sell
20-day EMA: 76.67 Sell
50-day EMA: 77.13 Sell
200-day EMA: 56.56 Buy

Freeport-McMoRan, Inc. Earnings Growth & FCX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.73 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Freeport-McMoRan, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):